CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
NDC 82046-291, Salicylic acid, liquid, from L'Oreal USA Products Inc.
- Product NDC
- 82046-291
- Status
- Listed
- Labeler
- L'Oreal USA Products Inc
- Dosage form
- LIQUID
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82046-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALICYLIC ACID20 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82046-291-01 | 82046029101 | 237 mL in 1 BOTTLE (82046-291-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 82046-291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82046-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82046-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.